Tag Archives: Transient receptor potential Melastatin 3

Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Posted on 07/16/2021 by wames

Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: role of Transient Receptor Potential Melastatin 3 Ion channels in pathophysiology and treatment, by Helene Cabanas,  Katsuhiko Muraki,  Natalie Eaton-Fitch,  Donald Ross Staines and Sonya Marshall-Gradisnik in … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS

Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME

Posted on 08/29/2018 by wames

Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from CFS/ME patients by Hélène Cabanas, Katsuhiko Muraki, Natalie Eaton, Cassandra Balinas, Donald Staines and Sonya Marshall-Gradisnik in Molecular Medicine 2018 24:44 [Published: 14 August 2018] Research abstract: … Continue reading →

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Loss of transient receptor potential Melastatin 3 ion channel function in natural killer cells from CFS/ME